Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00839137 · ClinicalTrials.gov registry record
Exercise Therapy for Asthma (ETA Trial)
A clinical trial, sponsored by Ohio State University.
- Terminated
- Registry status
- 13
- Enrollment target
NCT00839137: Clinical Trial study, sponsored by Ohio State University.
NCT00839137 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00839137 was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if a program of regular exercise can help reduce asthma symptoms and also reduce the inflammation caused by asthma. If successful, this would allow regular exercise to be recommended as a therapy for people with asthma, which could possibly reduce the amount of medicine that people with asthma need to control their asthma symptoms.
Primary Outcome
To determine the effectiveness of a behavioral intervention, exercise therapy as a primary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2003-12 |
| Est. Completion | 2009-12 |
Why NCT00839137 stopped before completion
NCT00839137 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00839137 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00839137 about?
NCT00839137 is a clinical study titled "Exercise Therapy for Asthma (ETA Trial)". The purpose of the study is to determine if a program of regular exercise can help reduce asthma symptoms and also reduce the inflammation caused by asthma. If successful, this would allow regular exercise to be recommended as a therapy for people with asthma, which could possibly reduce the amount ...
What is the current status of trial NCT00839137?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2003-12. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00839137?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia